Eris Lifesciences Limited (ERIS.NS) NSE

1,471.20

-5.9(-0.40%)

Updated at January 14 02:44PM

Currency In INR

Valuation

Market Cap189.48B
Enterprise Value212.03B
P/E Ratio48.29
PEG Ratio6.57
Price/Sales Ratio6.72
Price/Book Ratio6.49
Enterprise/Revenue7.5
Enterprise/EBITDA20.73

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.14
Operating Margin0.34

Management Effectiveness

Return On Assets0.06
Return On Equity0.13

Income Statement

Revenue28.79B
Revenue/Share219.16
Gross Profit21.49B
EBITDA10.17B
Net Income3.52B
Diluted EPS25.81

Balance Sheet

Total Cash839.2M
Total Cash/Share6.16
Total Debt23.89B
Total Debt/Equity0.77
Current Ratio0.91
Book Value Per Share257.1

Price History

52-Week Change15.23
52-Week High1,910
52-Week Low1,097.2
Moving Average 50 Days1,570.83
Moving Average 200 Days1,613.26

Statistics

Average Volume142,971
Shares Outstanding136.22M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate7.35
Trailing Annual Dividend Yield0.5
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A